[Congressional Bills 103th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2842 Introduced in House (IH)]

103d CONGRESS
  1st Session
                                H. R. 2842

 To amend the Public Health Service Act to provide for the development 
 or expansion of research centers on women's midlife health, including 
              menopause and menopausal health conditions.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             August 3, 1993

Mrs. Lloyd  (for herself, Mrs. Schroeder, Mrs. Maloney, Mrs. Meek, Ms. 
 Pelosi, Ms. Eddie Bernice Johnson of Texas, Mrs. Collins of Illinois, 
 and Ms. Woolsey) introduced the following bill; which was referred to 
                 the Committee on Energy and Commerce 

_______________________________________________________________________

                                 A BILL


 
 To amend the Public Health Service Act to provide for the development 
 or expansion of research centers on women's midlife health, including 
              menopause and menopausal health conditions.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Women's Midlife Health Research 
Act''.

SEC. 2. ESTABLISHMENT OF PROGRAM FOR RESEARCH CENTERS ON WOMEN'S 
              MIDLIFE HEALTH CARE, INCLUDING MENOPAUSE AND MENOPAUSAL 
              HEALTH CONDITIONS.

    Subpart 5 of part C of title IV of the Public Health Service Act 
(42 U.S.C. 285e et seq.) is amended by adding at the end the following 
section:

    ``research centers on menopause and menopausal health conditions

    ``Sec. 445G. (a) The Director of the Institute, after consultation 
with the advisory council for the Institute, shall provide for the 
development or expansion of not less than 5 centers for research on--
            ``(1) the process by which the functioning of the ovaries 
        diminishes or ceases completely (in this section referred to as 
        `menopause'); and
            ``(2) conditions arising from the diminished or complete 
        cessation of the functioning of the ovaries, whether occurring 
        naturally or otherwise (in this section referred to as 
        `menopausal health conditions').
    ``(b) Each center assisted under this section shall--
            ``(1)(A) use the facilities of a single institution or a 
        consortium of cooperating institutions; and
            ``(B) meet such qualifications as may be prescribed by the 
        Secretary;
            ``(2) conduct basic and clinical research into the natural 
        history of menopause in order to improve the state of medical 
        knowledge or methods regarding the cause, diagnosis, early 
        detection, prevention, control, and treatment of menopausal 
        health conditions;
            ``(3) develop multidisciplinary models of health care 
        regarding menopause and menopausal health conditions;
            ``(4) conduct educational and training programs on 
        menopause and menopausal health conditions for physicians, 
        scientists, and other health and allied health professionals;
            ``(5) conduct information and continuing education programs 
        for physicians and other health and allied health professionals 
        who provide care for patients with such conditions; and
            ``(6) conduct programs for the dissemination to the general 
        public of information on menopause and menopausal health 
        conditions.
    ``(c) In carrying out subsection (b)(2), the Director of the 
Institute shall ensure that centers assisted under this section--
            ``(1) conduct research on hormonal treatments for 
        menopausal health conditions, research on nonhormonal 
        treatments of symptoms arising from such conditions, and 
        research on the relationship between such conditions and 
        cardiovascular disease, osteoporosis, bone fractures, bladder 
        conditions, breast and uterine cancers, and other conditions 
        that research indicates may be relevant; and
            ``(2) conduct research to determine whether and to what 
        extent differences may exist, with respect to menopause and 
        menopausal health conditions, among various socioeconomic 
        groups, ethnic groups, and racial groups.
    ``(d) In carrying out subsection (a), the Director of the 
Institute, in consultation with the Director of NIH and the 
Administrator for Health Care Policy and Research, shall establish a 
program to develop protocols for the prevention and treatment of 
menopausal health conditions and other conditions regarding women's 
midlife health.
    ``(e) A center may use funds provided under subsection (a) to 
provide stipends for health professionals enrolled in educational or 
training programs described in subsection (b)(4).
    ``(f) The Director shall ensure that the activities of centers 
assisted under this section are coordinated among the centers.
    ``(g) The Director of the Institute shall, to the extent 
practicable, provide for an equitable geographical distribution of 
centers assisted under this section.
    ``(h) Support of a center under this section may be for a period of 
not to exceed five years. Such period may be extended by the Director 
of the Institute for one or more additional periods of not more than 
five years if the operations of such center have been reviewed by an 
appropriate technical and scientific peer review group established by 
the Director and if such group has recommended to the Director that 
such period should be extended.''.

                                 <all>